Based on the findings of Labelle and colleagues, platelets represent one of the first sources of TGF-β in circulation, which in turn activates the Smad and NF-κB signaling pathways in tumor cells, and promotes the transdifferentiation of CTCs into a mesenchymal-like phenotype [138,139,140]. This evidence concerns the gene TGFB1 and neoplasm.